BioSpace News Archive

Royal DSM, a global science-based company active in Health, Nutrition and Bioscience, comments on the findings from a recently published paper in Nature Medicine which reported that those infected with COVID-19 are at increased risk of long-term neurologic disorders that persist post infection.

Neogene Therapeutics, Inc., a global clinical-stage biotechnology company pioneering the discovery, development and manufacturing of next-generation T-cell receptor therapies, announced it has entered into a definitive agreement to be acquired by AstraZeneca.

True You Weight Loss has enrolled the first patient in the nation in a groundbreaking study to investigate the effects of gastric fundus ablation combined with Endoscopic Sleeve Gastroplasty (ESG) for the management of obesity.

atai Life Sciences N.V. announced today its appointment of Dr. Kirpekar to serve as the Company’s Chief Business Officer, effective today.

Glioblastoma multiforme (GBM), the most common type of brain cancer, is notoriously difficult to treat. Its tumor cells mutate rapidly, pushing into deep areas of the brain that can be difficult to reach with surgery and other treatments.

Tetra Bio-Pharma Inc. today announced the filing of three patent applications for its novel therapeutic, ARDS-003.

The Follicular Lymphoma Foundation announced it has awarded four research grants of up to $500 thousand each, a total of $2 million over the next two years, to support targeted and innovative research projects into Follicular Lymphoma – an incurable form of blood cancer and the second most common type of Non-Hodgkin Lymphoma.

A review published recently in the international scientific journal Biomedicines highlights the therapeutic benefits of amniotic fluid in restoring, repairing and regenerating damaged tissue across a range of human diseases and disorders.

Kineta, Inc. announced today that the Company will present at the JMP Securities Hematology and Oncology Summit, a virtual investor event to be held from December 6-7, 2022.

Today, Synexis ® , LLC announced the appointment of Dennis Doyle as the new chief executive officer (CEO) and James “Jimmy” Robert as its first chief commercial officer (CCO).